1Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul, Korea
2Wellness Academy, Seoul, Korea
3Department of Physical Education, Social Culture Graduate School, Jungwon University, Goesan, Korea
4ACE Exercise Science Center, Seosan, Chungnam, Korea
© 2024 Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherapy.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Author contributions
Conceptualization: KSC, DSY; Data curation: JYL; Formal analysis: KCJ; Investigation: KCJ; Methodology: JYL; Validation: JYL; Writing–original draft: JYL, KCJ; Writing–review & editing: KSC, DSY. All authors read and approved the final manuscript.
Conflicts of interest
Jong-Young Lee is an Editorial Board member of Cardiovascular Prevention and Pharmacotherapy, but was not involved in the peer reviewer selection, evaluation, or decision process of this article. The authors have no other conflicts of interest to declare.
Funding
This study was supported by a grant from the Korea Forestry Promotion Institute (Seoul, Korea).
Forest terrain | MET level | ||
---|---|---|---|
2 km/hr | 3 km/hr | 4 km/hr | |
Uphill | 5.41 | 7.61 | 9.82 |
Even | 3.75 | 5.12 | 6.49 |
Downhill | <3.75 | <5.12 | <6.49 |
Approximate average | 4.30 | 5.91 | 7.60 |
Values are presented as mean±standard deviation.
SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats per minute; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1C, glycated hemoglobin; hs-CRP, high-sensitivity C-reactive protein; MET, metabolic equivalent; FRS, Framingham risk score.
a)Significant difference within a group (P<0.05). b)Significant difference between groups (P<0.05).
Characteristic | Primary prevention group (n=11) | Secondary prevention group (n=17) |
---|---|---|
Age (yr) | 67.9±8.3 | 63.1±9.8 |
Sex | ||
Female | 9 | 4 |
Male | 2 | 13 |
Height (cm) | 158±7.3 | 164±8.4 |
Weight (kg) | 63.9±8.4 | 69±13.2 |
Clinical status | Hypertension, 54.5% | Post-PCI for coronary artery disease (chronic coronary syndrome, 50%; acute coronary syndrome, 50%) |
Diabetes mellitus, 54.5% | ||
Hyperlipidemia, 81.8% |
Exercise intensity | Relative intensity | Absolute intensity (MET) | |||
---|---|---|---|---|---|
HRR (%) | RPE | Young (20–39 yr) | Middle age (40–64 yr) | Older (≥65 yr) | |
Very light | <30 | <9 | <2.4 | <2.0 | <1.6 |
Light | 30–39 | 9–11 | 2.4–4.7 | 2.0–3.9 | 1.6–3.1 |
Moderate | 40–59 | 12–13 | 4.8–7.1 | 4.0–5.9 | 3.2–4.7 |
Vigorous | 60–89 | 14–17 | 7.2–10.1 | 6.0–8.4 | 4.8–6.7 |
Near maximum | ≥90 | ≥18 | ≥10.2 | ≥8.5 | ≥6.8 |
Forest terrain | MET level | ||
---|---|---|---|
2 km/hr | 3 km/hr | 4 km/hr | |
Uphill | 5.41 | 7.61 | 9.82 |
Even | 3.75 | 5.12 | 6.49 |
Downhill | <3.75 | <5.12 | <6.49 |
Approximate average | 4.30 | 5.91 | 7.60 |
Forest terrain | MET level | ||
---|---|---|---|
2 km/hr | 3 km/hr | 4 km/hr | |
Paved road (uphill) | 3.71 | 5.06 | 6.42 |
Boarded path | |||
Uphill | |||
Normal | 3.29 | 4.43 | 5.57 |
Steep | 3.98 | 5.47 | 6.96 |
Downhill | <3.37 | <4.55 | <5.73 |
Hiking trail | |||
Steep uphill | 4.52 | 6.28 | 8.05 |
Even | 3.37 | 4.55 | 5.73 |
Approximate average | 3.65 | 4.98 | 6.31 |
Adverse event | No. of patients | |
---|---|---|
Primary prevention group (n=11) | Secondary prevention group (n=17) | |
Heart attack/arrest | 0 | 0 |
Syncope | 0 | 0 |
Serious dyspnea | 0 | 0 |
Serious arrhythmia | 0 | 0 |
Hypoglycemia | 0 | 1 |
Intermittent claudication | 0 | 1 |
Serious fatigue | 0 | 0 |
Variable | Primary prevention group (n=11) | Secondary prevention group (n=17) | ||||
---|---|---|---|---|---|---|
Before | After | Difference | Before | After | Difference | |
Body weight (kg) | 63.9±8.4 | 61.5±7.6a) | –2.4 | 67.8±12.4 | 66.2±12.6 | –1.6 |
Body fat (%) | 34.5±8.2 | 31.9±8.8a) | –2.6 | 29.1±7.6 | 26.4±6.8a) | –2.7 |
Muscle mass (kg) | 22.5±3.7 | 22.7±3.8 | 0.2 | 26.2±4.8 | 26.6±5.0 | 0.4 |
SBP (mmHg) | 132.4±7.3 | 123.3±12.4a,b) | –9.1 | 120.6±16.8 | 116.9±12.8 | –3.7 |
DBP (mmHg) | 76.4±7.3 | 76.9±9.5a) | 0.5 | 72.5±10.6 | 70.2±10.1 | –2.3 |
Heart rate (bpm) | ||||||
At rest | 77.2±9.2 | 64.1±8.8a) | –13.1 | 70.7±11.9 | 64.5±7.0a) | –6.2 |
At maximum | 145.2±23.2 | 154.4±26.1a) | 9.2 | 137.2±23.6 | 143.3±19.9 | 6.1 |
TC (mg/dL) | 187.8±43.1 | 179.8±42.1b) | –8.0 | 128.8±23.6 | 122.9±18.0 | –5.9 |
LDL-C (mg/dL) | 116.7±40.6 | 105.9±38.2a,b) | –11.0 | 65.2±20.6 | 56.0±13.8a) | –9.2 |
HDL-C (mg/dL) | 56.6±9.1 | 64.6±11.5a) | 8.0 | 51.4±11.6 | 52.1±12.9 | 0.7 |
Triglyceride (mg/dL) | 104.0±36.3 | 94.9±47.6 | –9.1 | 129.9±93.4 | 112.4±46.7 | –17.5 |
FBG (mg/dL) | 113.4±17.9 | 105.5±15.1 | –7.9 | 97.4±15.5 | 103.6±26.5 | 6.2 |
HbA1C (%) | 5.9±0.6 | 5.8±0.4a) | –0.1 | 6.0±0.8 | 5.8±0.7 | –0.2 |
hs-CRP (mg/L) | 1.16±1.38 | 1.20±2.04b) | 0.04 | 0.4±0.4 | 0.2±0.3a) | –0.2 |
MET | 9.4±1.8 | 11.7±1.5a) | 2.3 | 10.8±2.6 | 11.8±2.7a) | 1.0 |
FRS | 11.2±5.1 | 6.5±3.4a) | –4.7 | 7.4±3.8 | 7.4±3.9 | –0.03 |
Values are presented as mean±standard deviation or number only. PCI, percutaneous coronary intervention.
MET, metabolic equivalent; HRR, heart rate reserve; RPE, relative perceived exertion.
MET, metabolic equivalent.
MET, metabolic equivalent.
Values are presented as mean±standard deviation. SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats per minute; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1C, glycated hemoglobin; hs-CRP, high-sensitivity C-reactive protein; MET, metabolic equivalent; FRS, Framingham risk score. a)Significant difference within a group (P<0.05). b)Significant difference between groups (P<0.05).